Table 1.
Day | Group | BWGT (gm) | UV (mL/day) | UprotV (mg/day) | UcreV (mg/day) | Pcre (mg/dL) | Ccre (ml/min/100g BWGT) |
---|---|---|---|---|---|---|---|
CON1 | SS-0.4% (N=8) | 289±8 | 0.22±.02 | 53±18 | 8.4±.4 | .25±.01# | .84±.06 |
TC-SS; 0.4% (N=6) | 291±4 | 0.2±.02 | 42±5 | 7.3±.6 | .21±.01 | .85±.06 | |
HS7 | SS-4.0% (N=8) | 315±6* | 1.5±.1* # | 130±18* | 10.6±.6* | .23±.02 | 1.08±.06* |
TC-SS; 0.4% (N=6) | 316±8* | 0.3±.03 | 68±11 | 8.8±.7 | .22±.01 | .90±.06 | |
HS14 | SS-4.0% (N=8) | 339±8* | 1.7±2* # | 173±26* # | 12.2±.8* | .26±.01 | .98±.05 |
TC-SS; 0.4% (N=6) | 335±6* | 0.57±.2 | 81±17 | 10.9±.2* | .24±.02 | .92±.12 | |
HS21 | SS-4.0% (N=8) | 353±8* | 2.1±2* # | 237±37* # | 14.0±.9* | .29±.02* | .98±.06 |
TC-SS; 0.4% (N=6) | 350±9* | 0.67±.2* | 83±10 | 12.0±.4* | .27±.02* | .91±.04 |
indicates significant difference from LS control p< 0.05 ;
indicates significant difference from the time control group on the same day p < 0.05